TET2 and acute myeloid leukemia: To investigate whether promoter hypermethylation of TET2 resulted in reduced TET2 expression, we performed MSP to analyze TET2 methylation and qRT-PCR to measure TET2 expression in samples from 68 ND AML patients (Supplementary Table 2) and 15 controls.